New targets for overcoming melanoma resistance identified
HONG KONG A study by Japanese researchers has identified two promising and selective candidate therapeutic targets that could prove important in the development of new treatments aimed at overcoming drug resistance in melanoma. Drug resistance is a major problem in the treatment of melanoma patients, for example with drugs targeting BRAF-mutated melanomas such as Zelboraf.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST